Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
04.03.25
/
50%
€133.42
Target price
04.03.26
€146.25
Performance (%)
-20.00%
Price
18.12.25
€106.74
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.00%. This prediction currently runs until 04.03.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.638% | 1.638% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $138.00 to $154.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.08
01.10.25
01.10.25
€133.73
01.10.26
01.10.26
-7.25%
18.12.25
18.12.25
